The effect of ketanserin on cardiovascular reflexes in conscious normotensive and spontaneously hypertensive rats

European Journal of Pharmacology
R E WiddopB Jarrott


The effect of ketanserin (3 mg/kg i.v.) on the baroreceptor heart rate reflex and the Bezold-Jarisch reflex was examined in conscious Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). In the control situation (before ketanserin treatment), reflex bradycardia in response to phenylephrine (baroreflex) and phenyldiguanide (Bezold-Jarisch reflex) were impaired in SHR as compared with WKY, while reflex tachycardia in response to nitroprusside was similar in the two groups. However, after ketanserin administration in SHR, there was a reversal of the baroreflex-mediated tachycardia in response to nitroprusside into a bradycardic response. The nitroprusside-induced bradycardia was not caused by the release of 5-HT stimulating chemosensitive vagal afferents since the 5-HT3 receptor antagonist MDL 72222 did not block this response. In the same SHR, the Bezold-Jarisch reflex evoked by phenyldiguanide and the phenylephrine-induced bradycardia were potentiated by ketanserin. All the above effects of ketanserin were less evident in the WKY. Ketanserin did not alter vagal efferent function in anaesthetized SHR since it did not affect bradycardia induced by electrical stimulation of the vagus nerve. Therefore, it is suggested ...Continue Reading


Dec 1, 1985·Acta Physiologica Scandinavica·P SkoogP Thorén
Jul 1, 1987·Journal of Cardiovascular Pharmacology·J F SmitsH A Struyker-Boudier
Jan 1, 1988·Journal of Cardiovascular Pharmacology·T Hedner, B Persson
Jan 1, 1988·Journal of Cardiovascular Pharmacology·H L ElliottJ L Reid
Aug 1, 1988·Journal of Hypertension·P F SempleA F Lever
Dec 1, 1988·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·P A van Zwieten
Jul 31, 1985·European Journal of Pharmacology·A G Ramage
Dec 1, 1988·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·A U FerrariG Mancia
Jan 1, 1987·European Journal of Clinical Pharmacology·A BerdeauxJ F Giudicelli
Sep 1, 1988·Japanese Journal of Pharmacology·M Matsumoto
Jun 1, 1988·Journal of the Autonomic Nervous System·A J VerberneW J Louis
Apr 1, 1987·Postgraduate Medical Journal·P C WallerL E Ramsay
Sep 1, 1982·Journal of Cardiovascular Pharmacology·J R Fozard
Jun 1, 1982·Clinical Science·H A Struyker-BoudierH Van Essen
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·J V Jones, J S Floras
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss


Aug 1, 1994·Aging : Clinical and Experimental Research·L W DavidowR D Buñag
Jan 16, 2002·European Journal of Pharmacology·R D BuñagJennifer R Mellick
Jun 30, 2007·Clinical and Experimental Pharmacology & Physiology·Fu-Ming ShenDing-Feng Su
Feb 27, 2003·Clinical and Experimental Pharmacology & Physiology·Chao-Yu MiaoDing-Feng Su
Aug 11, 2011·Journal of Forensic Sciences·Alan R Felthous
Sep 14, 2017·Medicinal Research Reviews·Xiao-Fei ShangKuo-Hsiung Lee

Related Concepts

Phenyl biguanide monohydrochloride
MDL 72699
Atropine Sulfate Anhydrous
Diastolic Blood Pressure
Cardiovascular System
Dose-Response Relationship, Drug
Electric Stimulation Technique
Pulse Rate

Related Feeds


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.